Original language | English (US) |
---|---|
Pages (from-to) | 1219-1220 |
Number of pages | 2 |
Journal | JAMA - Journal of the American Medical Association |
Volume | 321 |
Issue number | 12 |
DOIs | |
State | Published - Mar 26 2019 |
Funding
from the National Cancer Institute and the James C. Bradford Jr Melanoma Fund; serving on advisory boards for Array Biopharma, Bristol-Myers Squibb, Incyte, Merck, Novartis, and Genoptix; and receiving research grants from Bristol-Myers Squibb and Incyte. Dr Chandra reported receiving consulting fees from Bristol-Myers Squibb, EMD Serono, Regeneron, Novartis, and Array Biopharma. Dr Sosman reported receiving funding from the Mary Hendrickson-Johnson American Cancer Society Melanoma Research Professorship; serving on advisory boards for Array Biopharma, Bristol-Myers Squibb, and Genentech; and receiving research funding from Merck.
ASJC Scopus subject areas
- General Medicine